Tg Therapeutics (TGTX) Income towards Parent Company (2011 - 2026)
Tg Therapeutics (TGTX) posted Income towards Parent Company of $7.78 million for Q2 2026, down 72.4% from $28.19 million a year earlier and down 60.7% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) Income towards Parent Company (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Tg Therapeutics was $441.49 million, up 630.2% year-over-year; for FY2025, it came in at $447.18 million.
- In prior years, Tg Therapeutics' Income towards Parent Company was $23.38 million in FY2024 (+84.5%), $12.67 million in FY2023, -$223.81 million in FY2022 and -$348.1 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Income towards Parent Company since Q1 2025.
- On a year-over-year basis, Income towards Parent Company increased in two of the last five quarters, with growth averaging 86.1%.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was $19.78 million (Q1 2026), $23.04 million (Q4 2025) and $390.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Tg Therapeutics | 8.31 Bn | 7.70 Bn | 199.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.78 Mn |
| Mar 31, 2026 | 19.78 Mn |
| Dec 31, 2025 | 23.04 Mn |
| Sep 30, 2025 | 390.90 Mn |
| Jun 30, 2025 | 28.19 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 23.33 Mn |
| Sep 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | -10.71 Mn |
| Dec 31, 2023 | -14.42 Mn |
| Sep 30, 2023 | 113.93 Mn |
| Jun 30, 2023 | -47.61 Mn |
| Mar 31, 2023 | -39.23 Mn |
| Dec 31, 2022 | -78.47 Mn |
| Sep 30, 2022 | -35.82 Mn |
| Jun 30, 2022 | -40.51 Mn |
| Mar 31, 2022 | -69.01 Mn |
| Dec 31, 2021 | -93.34 Mn |
| Sep 30, 2021 | -85.64 Mn |
API Access
Tg Therapeutics Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();